itraconazole has been researched along with micafungin in 80 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 46 (57.50) | 29.6817 |
2010's | 31 (38.75) | 24.3611 |
2020's | 3 (3.75) | 2.80 |
Authors | Studies |
---|---|
Clemons, KV; Luque, JC; Stevens, DA | 1 |
Denning, DW; Morrissey, G; Morrissey, J; Warn, PA | 1 |
Yamaguchi, H | 1 |
Du Toit, A; Esterhuizen, K; Jacobs, P; Wood, L | 1 |
Ikeda, F | 1 |
Fujihara, N; Ichiyama, S; Iinuma, Y; Kudo, T; Saito, T; Takakura, S | 1 |
Abe, N; Aihara, M; Fukuda, S; Iwasaki, M; Komatsu, M; Matsuo, S; Nagasaka, Y; Shimakawa, K | 1 |
Denning, DW; Guinea, J; Sharp, A; Warn, PA | 1 |
Maruyama, T; Takagi, T; Yuda, H | 1 |
Steinbach, WJ | 1 |
Niwa, T; Shiraga, T; Takagi, A | 1 |
Fujita, J; Furugen, M; Haranaga, S; Higa, F; Saitou, A; Shinzato, T; Shiroma, R; Tateyama, M; Touyama, M; Yara, S | 1 |
Endo, H; Kondo, H; Kume, H; Nomura, T; Yoshida, H | 1 |
Abe, N; Azuma, T; Hatta, K; Ishimaru, H; Komatsu, M; Okamoto, M | 1 |
Fujihara, M; Fujita, Y; Iwato, K; Mikami, Y; Murayama, SY; Myoken, Y; Sugata, T | 1 |
Clemons, KV; Stevens, DA | 1 |
Fukushima, K; Hyon, SH; Park, BJ; Park, JC; Taguchi, H; Takatori, K | 1 |
Fujii, M; Kato, M; Kawabata, A; Sugino, Y; Yagi, A | 1 |
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
Chihara, K; Fujiwara, K; Yamashina, A | 1 |
Maesaki, S | 2 |
Homma, S; Izumikawa, K; Kawabata, M; Kishi, K; Miyamoto, A; Ohtsu, Y; Sakamoto, S; Takaya, H; Tsuboi, E; Yoshimura, K | 1 |
Adachi, M; Andou, K; Hirose, T; Horichi, N; Hosaka, T; Ishida, H; Kusumoto, S; Nakashima, M; Ohnishi, T; Okuda, K; Shirai, K; Sugiyama, H; Yamaoka, T | 1 |
Hashinaga, K; Hiramatsu, K; Ishii, H; Iwata, A; Kadota, J; Kishi, K; Kohno, K; Kushima, H; Ogata, M; Ohama, M; Saikawa, T; Tokimatsu, I; Umeki, K | 1 |
Carrillo, AJ; Guarro, J; Mariné, M; Pastor, J; Quindós, G; Serena, C | 1 |
Aihara, K; Fukui, M; Ishitoko, M; Itotani, R; Kagioka, H; Matsumoto, M; Suzuki, S; Takemura, M | 1 |
Guarro, J; Mariné, M; Pastor, FJ; Rodriguez, MM; Ruíz-Cendoya, M | 1 |
Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L | 1 |
Fujii, Y; Inase, N; Yoshizawa, Y | 1 |
Gabazza, EC; Maruyama, T; Morser, J; Taguchi, O; Takei, Y | 1 |
Kato, T; Ohnishi, R; Sano, K; Suzuki, T; Yasuda, S | 1 |
Denning, DW; Morrissey, G; Sharp, A; Warn, PA | 1 |
Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA | 1 |
Iwashima, Y; Morita, H; Nakamura, A; Oguri, T; Sato, S; Uemura, T | 1 |
Abe, S; Asada, M; Hata, K; Horii, T; Inoue, S; Matsukura, M; Miyazaki, M; Murai, N; Nakamoto, K; Shirotori, S; Tanaka, K; Watanabe, NA; Yoshimatsu, K | 1 |
Hirano, K; Hosogaya, N; Ide, S; Imamura, Y; Iwanaga, N; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Mihara, T; Minematsu, A; Miyazaki, T; Morinaga, Y; Nakamura, S; Nishino, T; Takazono, T; Tashiro, M; Tashiro, T; Tsukamoto, M; Yamamoto, Y; Yanagihara, K; Yasuoka, A | 1 |
Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M | 1 |
Fujita, M; Harada, E; Ikegame, S; Kajiki, A; Matsumoto, T; Nakanishi, Y; Ouchi, H; Tao, Y; Uchino, J; Watanabe, K | 1 |
Chen, H; Chen, X; Han, M; Hu, J; Huang, H; Huang, X; Lai, Y; Liu, T; Wang, J; Wu, D; Zhu, H; Zou, P | 1 |
Mikamo, H; Mochizuki, K; Murase, H; Suematsu, H; Yamagishi, Y; Yasuda, Y | 1 |
Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L | 1 |
Murakami, H; Tashiro, M; Tateda, K; Yamaguchi, K; Yoshizawa, S | 1 |
Yoshida, M | 1 |
Furuya, N; Mano, Y; Morishige, H; Oguri, T | 1 |
Ishibashi, Y; Kobayashi, A; Oikawa, Y; Sugiyama, K; Tokoro, M; Yamazaki, N; Yokogawa, H | 1 |
Curfs-Breuker, I; de Hoog, GS; Feng, P; Meis, JF; Najafzadeh, MJ; Rezaei-Matehkolaei, A; Saradeghi Keisari, M; Shamsian, SA; Vicente, VA | 1 |
Fujisaki, J; Hamada, T; Hirabayashi, D; Kamikawa, Y; Mori, Y; Nagayama, T; Sakamoto, R; Sugihara, K | 1 |
Horiuchi, C; Ikeda, T; Iwanaga, N; Kamiya, C; Katsuragi, S; Kobayashi, Y; Miyoshi, T; Neki, R; Sata, M; Tanaka, H; Yamanaka, K; Yamashita, Y; Yoshimatsu, J | 1 |
Hishiya, N; Kasahara, K; Maeda, K; Matsumoto, K; Mikasa, K; Morita, K; Nario, K; Ogawa, T; Tsujimoto, K; Uno, K; Yamada, Y | 1 |
Chowdhary, A; Curfs-Breuker, I; de Hoog, GS; Hagen, F; Madrid, H; Meis, JF | 1 |
Choi, CW; Jang, JH; Jeong, SH; Kim, DY; Kim, JS; Kim, SH; Mun, YC; Park, JS | 1 |
Al-Hatmi, AM; Bonifaz, A; Curfs-Breuker, I; De Hoog, GS; Meis, JF; Meletiadis, J | 1 |
Feng, B; Shen, JL; Tang, XF; Xu, HQ; Xu, SX | 1 |
Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Koenderink, JB; Lempers, VJ; Russel, FG; van den Heuvel, JJ | 1 |
Biehl, LM; Bücker, V; Cornely, OA; Franke, B; Liss, B; Markiefka, B; Persigehl, T; Scheid, C; Vehreschild, JJ; Vehreschild, MJ; Wisplinghoff, H | 1 |
Hsueh, PR; Wang, H; Xu, YC | 1 |
Almeida-Paes, R; Barbedo, LS; de Oliveira, JCA; Dos Santos, ALS; Figueiredo-Carvalho, MHG; Ramos, LS; Zancopé-Oliveira, RM | 1 |
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E | 1 |
Fujita, H; Fujiwara, SI; Fukuda, T; Gotoh, M; Iino, M; Jo, Y; Kanda, Y; Kimura, SI; Matsumura, I; Nakamura, S; Okamoto, A; Oyake, T; Saburi, Y; Sakaida, E; Shiratori, S; Takamatsu, Y; Tamura, K; Yamaguchi, H; Yamanouchi, J | 1 |
Liang, G; Liu, M; Liu, W; Zeng, R; Zheng, H; Zheng, N | 1 |
Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C | 1 |
Alastruey-Izquierdo, A; Alcazar-Fuoli, L; Cuenca-Estrella, M; Mellado, E; Rodriguez-Tudela, JL | 2 |
Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chu, CC; Hsueh, PR; Ruan, SY | 1 |
Alastruey-Izquierdo, A; Castelli, MV; Cuenca-Estrella, M; Cuesta, I; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
Müller, FM; Salvenmoser, S; Seidler, MJ | 1 |
Garcia-Effron, G; Kontoyiannis, DP; Lewis, RE; Perlin, DS | 1 |
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Lass-Flörl, C; Perkhofer, S; Rodriguez-Tudela, JL | 1 |
Dimopoulos, G; Falagas, ME; Velegraki, A | 1 |
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE | 1 |
Calvo, E; Guarro, J; Pastor, FJ; Rodríguez, MM; Salas, V; Sutton, DA | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Inamine, T; Izumikawa, K; Kakeya, H; Kohno, S; Miyazaki, T; Miyazaki, Y; Nagayoshi, Y; Saijo, T; Seki, M; Yamamoto, Y; Yamauchi, S; Yanagihara, K | 1 |
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Cuesta, I; Rodriguez-Tudela, JL; Walther, G | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
13 review(s) available for itraconazole and micafungin
Article | Year |
---|---|
[Antifungal drug].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Design; Drug Resistance, Fungal; Echinocandins; Fluconazole; Fluorouracil; Fungi; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Polyenes; Pyrimidines | 2003 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
[Drug-drug interaction of antifungal drugs].
Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microsomes, Liver; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
[The future of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2007 |
[New development in the treatment of deep-seated mycoses].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Treatment of invasive candidal infections: systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Odds Ratio; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Clinical efficacies of antifungal injections].
Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Injections; Itraconazole; Lipopeptides; Liposomes; Micafungin; Mycoses; Organophosphates; Pyrimidines; Triazoles; Voriconazole | 2008 |
Traditional and emerging antifungal therapies.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2010 |
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.
Topics: Antifungal Agents; Echinocandins; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Itraconazole; Lipopeptides; Micafungin; Mycoses; Randomized Controlled Trials as Topic; Voriconazole | 2016 |
Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
Topics: Anidulafungin; Antifungal Agents; Asia; Azoles; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Candidiasis; Candidiasis, Invasive; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Incidence; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Phenotype; Prevalence; Voriconazole | 2016 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
4 trial(s) available for itraconazole and micafungin
Article | Year |
---|---|
The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergilloma.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Drug Therapy, Combination; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Radiography, Thoracic; Treatment Outcome | 2012 |
Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Drug Administration Schedule; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Neutropenia; Treatment Outcome | 2012 |
Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antifungal Agents; Echinocandins; Empirical Research; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Itraconazole; Length of Stay; Lipopeptides; Male; Micafungin; Middle Aged; Prospective Studies; Treatment Outcome; Young Adult | 2016 |
D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial.
Topics: Adult; Aged; Antifungal Agents; Febrile Neutropenia; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukocyte Count; Male; Micafungin; Middle Aged; Mycoses; Neutrophils; Young Adult | 2020 |
63 other study(ies) available for itraconazole and micafungin
Article | Year |
---|---|
Efficacy of micafungin alone or in combination against systemic murine aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Female; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic | 2003 |
Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Colony Count, Microbial; Drug Resistance, Fungal; Echinocandins; Immunosuppressive Agents; Itraconazole; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Microbial Sensitivity Tests; Neutropenia; Peptides, Cyclic | 2003 |
Eradication of invasive mucormycosis--effectiveness of the Echinocandin FK463.
Topics: Acute Disease; Adolescent; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Drug Evaluation; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid; Lipopeptides; Lipoproteins; Male; Micafungin; Mucormycosis; Multiple Organ Failure; Peptides, Cyclic; Periodontal Abscess; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sinusitis; Splenectomy; Systemic Inflammatory Response Syndrome; Transplantation, Homologous | 2003 |
[Antifungal activity and clinical efficacy of micafungin sodium (Funguard)].
Topics: Adult; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mice; Peptides, Cyclic | 2003 |
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
[In vitro activity of a new semisynthetic echinocandin, micafungin, against clinical isolates of Candida species isolated in Tenri Hospital].
Topics: Amphotericin B; Antifungal Agents; Candida; DNA Fingerprinting; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Random Amplified Polymorphic DNA Technique; Time Factors | 2003 |
Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Echinocandins; Gases; Hypoxia; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Oxygen; Peptides, Cyclic | 2004 |
[Combination therapy of micafungin and itraconazole for a case of pulmonary aspergillosis].
Topics: Administration, Oral; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Female; Humans; Infusions, Intravenous; Itraconazole; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Micafungin; Peptides, Cyclic; Treatment Outcome | 2005 |
[Two cases of pulmonary aspergillosis successfully treated with combinated micafungin and itraconazole therapy].
Topics: Adult; Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Peptides, Cyclic; Tomography, X-Ray Computed | 2005 |
[Combined effect of micafangin and itraconazole on severe aspergillosis of the bilateral pleural cavities in a patient with Wegener's granulomatosis].
Topics: Adult; Antifungal Agents; Aspergillosis; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Granulomatosis with Polyangiitis; Humans; Itraconazole; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Peptides, Cyclic; Pleural Cavity | 2006 |
[Successful treatment of invasive sinus aspergillosis with micafungin and itraconazole].
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cavernous Sinus; Combined Modality Therapy; Echinocandins; Ethmoid Sinusitis; Female; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Orbit; Peptides, Cyclic; Sinusitis; Sphenoid Sinusitis | 2006 |
Early diagnosis and successful management of atypical invasive Aspergillus sinusitis in a hematopoietic cell transplant patient: a case report.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Debridement; DNA, Fungal; Drug Therapy, Combination; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Lipoproteins; Lymphoma, Non-Hodgkin; Male; Maxillary Diseases; Maxillary Sinus; Micafungin; Middle Aged; Opportunistic Infections; Peptides, Cyclic; Renal Insufficiency; Sinusitis; Treatment Outcome | 2006 |
Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis.
Topics: Aminoglycosides; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Antagonism; Drug Therapy, Combination; Echinocandins; Female; Immunosuppression Therapy; Itraconazole; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Micafungin; Mice; Mice, Inbred DBA; Peptides, Cyclic; Survival Analysis | 2006 |
Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catechin; Dose-Response Relationship, Drug; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Species Specificity | 2006 |
[Micafungin therapy for a case of chronic necrotizing pulmonary aspergillosis].
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Therapy, Combination; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Necrosis; Peptides, Cyclic | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
[Preoperative antifungal agent for pulmonary aspergilloma].
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Echinocandins; Humans; Infusions, Intravenous; Itraconazole; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Peptides, Cyclic; Pneumonectomy; Treatment Outcome | 2006 |
Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Peptides, Cyclic; Radiography; Retrospective Studies; Treatment Outcome | 2007 |
[Two cases of successfully treated invasive pulmonary aspergillosis following influenza virus infection].
Topics: Aged; Alphainfluenzavirus; Amphotericin B; Antifungal Agents; Aspergillosis; Betainfluenzavirus; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Female; Humans; Influenza, Human; Itraconazole; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Peptides, Cyclic | 2007 |
Invasive pulmonary aspergillosis with hematological malignancy caused by Aspergillus terreus and in vitro susceptibility of A. terreus isolate to micafungin.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Drug Therapy, Combination; Echinocandins; Humans; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Sputum; Stem Cell Transplantation | 2007 |
In vitro activity of micafungin combined with itraconazole against Candida spp.
Topics: Antifungal Agents; Candida; Drug Synergism; Echinocandins; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests | 2007 |
[Case of bronchocentric granulomatosis that became recognized in the course of allergic bronchopulmonary aspergillosis].
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Bronchial Diseases; Clarithromycin; Drug Therapy, Combination; Echinocandins; Granuloma; Humans; Itraconazole; Lipopeptides; Lipoproteins; Macrolides; Male; Methylprednisolone; Micafungin; Middle Aged; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
In vitro interactions of itraconazole and micafungin against clinically important filamentous fungi.
Topics: Antifungal Agents; Drug Synergism; Echinocandins; Fungi; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Quality Control | 2008 |
Different bile concentration of micafungin and itraconazole in a patient with candidal cholecystitis.
Topics: Aged, 80 and over; Antifungal Agents; Bile; Candidiasis; Cholecystitis; Echinocandins; Esophageal Neoplasms; Humans; Itraconazole; Lipopeptides; Male; Micafungin | 2009 |
[Short-term efficacy evaluation of chronic pulmonary aspergillosis treated with micafangin and maintenance therapy of itraconazole].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Chronic Disease; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Pulmonary Aspergillosis | 2009 |
Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Injections, Intraperitoneal; Injections, Intravenous; Itraconazole; Kidney; Lipopeptides; Liver; Male; Micafungin; Mice; Survival Analysis; Treatment Outcome | 2010 |
[Case of chronic necrotizing pulmonary aspergillosis complicated by elevated eosinophils and serum IgE].
Topics: Aged; Antibodies, Fungal; Antifungal Agents; Aspergillus fumigatus; Drug Therapy, Combination; Echinocandins; Eosinophils; Humans; Immunoglobulin E; Invasive Pulmonary Aspergillosis; Itraconazole; Leukocyte Count; Lipopeptides; Male; Micafungin; Treatment Outcome | 2010 |
In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds.
Topics: Aminopyridines; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Cell Line; Echinocandins; Fluconazole; Fungi; Fusarium; Humans; Isoxazoles; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Paecilomyces; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Yeasts | 2011 |
Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Female; Fungal Proteins; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Mutation; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2012 |
Discrepancy of in-vitro data and clinical efficacy of micafungin against Candida tropicalis endophthalmitis.
Topics: Aged; Antifungal Agents; beta-Glucans; Candida tropicalis; Candidiasis; Echinocandins; Endophthalmitis; Female; Fundus Oculi; Humans; Itraconazole; Lipopeptides; Micafungin | 2012 |
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
[Isolation rate and susceptibilities of candida species from blood, vascular catheter, urine and stool].
Topics: Antifungal Agents; Candida; Candidiasis; Diagnosis, Differential; Echinocandins; Feces; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Vascular Access Devices | 2012 |
[Infectious diseases: progress in diagnosis and treatment. Topics: IV. Towards containing infectious diseases: 3. Development of new antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
In vivo laser confocal microscopy findings of radial keratoneuritis in patients with early stage Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Adolescent; Adult; Antifungal Agents; Chlorhexidine; Contact Lenses, Hydrophilic; Cornea; Cranial Nerve Diseases; Debridement; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microscopy, Confocal; Neuritis; Ophthalmic Nerve; Prospective Studies; Risk Factors; Young Adult | 2013 |
In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Autoimmune Diseases; Bacterial Load; Candida; Candida albicans; Candida glabrata; Candidiasis, Oral; Coinfection; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Miconazole; Microbial Sensitivity Tests; Middle Aged; Xerostomia | 2014 |
Antifungal susceptibility of Candida isolates at one institution.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Health Facilities; Humans; Itraconazole; Japan; Lipopeptides; Micafungin; Time Factors; Voriconazole | 2014 |
Chronic invasive sinus and intracerebral aspergillosis controlled by combination therapy with micafungin and a daily dose of 400 mg itraconazole oral solution.
Topics: Aged; Antifungal Agents; Aspergillosis; Central Nervous System Fungal Infections; Chronic Disease; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Micafungin; Paranasal Sinus Diseases; Radiography | 2015 |
In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Genotype; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitis.
Topics: Antifungal Agents; Dermatomycoses; Drug Combinations; Drug Interactions; Drug Synergism; Echinocandins; Fusariosis; Fusarium; Itraconazole; Keratitis; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Voriconazole | 2016 |
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
Topics: Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Echinocandins; Fluconazole; HEK293 Cells; Humans; Itraconazole; Lipopeptides; Micafungin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Triazoles; Voriconazole | 2016 |
A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Cohort Studies; Echinocandins; Female; Hematologic Diseases; Humans; Incidence; Invasive Fungal Infections; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Triazoles; Young Adult | 2016 |
Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Drug Resistance, Fungal; Echinocandins; Fluconazole; Hydrolysis; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Virulence | 2017 |
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult | 2019 |
Effects of Itraconazole and Micafungin on Aspergillus fumigatus Biofilms.
Topics: Antifungal Agents; Aspergillus fumigatus; Azoles; Biofilms; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Micafungin; Microbial Sensitivity Tests | 2021 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis | 2008 |
Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification.
Topics: Antifungal Agents; Aspergillus fumigatus; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Nuclear Proteins; Phylogeny; Polymerase Chain Reaction; Sequence Analysis, DNA; Tubulin | 2008 |
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Susceptibility testing and molecular classification of Paecilomyces spp.
Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; Echinocandins; Itraconazole; Microbial Sensitivity Tests; Paecilomyces; Phylogeny | 2008 |
Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biofilms; Bronchi; Cells, Cultured; Cystic Fibrosis; Drug Resistance, Fungal; Epithelial Cells; Humans; Microbial Sensitivity Tests; Microscopy, Confocal; Microscopy, Electron, Scanning; Respiratory Tract Infections | 2008 |
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged | 2008 |
In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; DNA, Fungal; Humans; Microbial Sensitivity Tests; Soil Microbiology | 2009 |
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2009 |
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain | 2009 |
Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri.
Topics: Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny | 2009 |
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.
Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia | 2009 |
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Kidney; Male; Mice; Mucormycosis; Rhizopus; Triazoles | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.
Topics: Animals; Antifungal Agents; Base Sequence; Calcineurin; Candida glabrata; Candidiasis; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Female; Fungal Proteins; Genes, Fungal; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation; Opportunistic Infections; Transcription Factors; Virulence | 2010 |
Antifungal susceptibility profile of human-pathogenic species of Lichtheimia.
Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Pyrimidines; Triazoles; Voriconazole | 2010 |